Citi lowered the firm’s price target on iRhythm to $85 from $100 and keeps a Neutral rating on the shares post the Q3 report. The firm says the company’s “conservative” guidance raise is offset by elevated expenses.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IRTC:
- iRhythm sees FY23 revenue $487.5M-$490M, consensus $488.53M
- iRhythm reports Q3 EPS (89c), consensus (66c)
- iRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023
- iRhythm price target lowered to $100 from $138 at Truist
- iRhythm price target lowered to $135 from $149 at Morgan Stanley
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue